3-AP and Cytarabine in Treating Patients With Hematologic Cancer

NCT00064090 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Leukemia
Myelodysplastic Syndromes
Myelodysplastic/Myeloproliferative Neoplasms

Interventions

DRUG: cytarabine
DRUG: triapine

Sponsor

Vion Pharmaceuticals